The role of iron in neurotoxicity: A study of novel antimalarial drugs

S. L. Smith, J. L. Maggs, G. Edwards, S. A. Ward, B. K. Park, W. G. McLean

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)

Abstract

The antimalarial drug artemisinin and its derivatives display neurotoxicity in animal studies in vive and in neuronal cells in vitro. Their toxicity may be due to an interaction of iron with the endoperoxide bridge of the derivative to produce toxic free radicals and/or other toxic metabolites. In this study, 0.3 μM artemether (AEM) in the presence of 2 μM haemin significantly inhibited the outgrowth of neurites from differentiating NB2a neuroblastoma cells by up to 76%. The antioxidants ascorbic acid and glutathione completely protected against this toxicity at a concentration of 100 μM. AEM was found to be partially converted to two isomeric products, which were identified as the tetrahydrofuran acetate isomer of AEM and 3α- hydroxydesoxyartemether.

Original languageEnglish
Pages (from-to)557-560
Number of pages4
JournalNeuroToxicology
Volume19
Issue number4-5
Publication statusPublished - 1 Sept 1998
Externally publishedYes

Keywords

  • Artemisinin
  • Free Radicals
  • Iron
  • Neurite
  • Neurotoxicity

Fingerprint

Dive into the research topics of 'The role of iron in neurotoxicity: A study of novel antimalarial drugs'. Together they form a unique fingerprint.

Cite this